SEATTLE, May 11, 2023 /PRNewswire/ -- Lumen Bioscience, "Lumen," a clinical-stage biotechnology company developing biologic drugs for highly prevalent diseases, today announced a new $8.8 million ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果一些您可能无法访问的结果已被隐去。
显示无法访问的结果